Abingdon Health (ABDX)

Sector:

Health Care

Index:

FTSE AIM All-Share

 5.00p
   
  • Change Today:
      0.000p
  • 52 Week High: 37.89
  • 52 Week Low: 4.50
  • Currency: UK Pounds
  • Shares Issued: 121.72m
  • Volume: 334,131
  • Market Cap: £6.09m

Abingdon Health wins 'significant' rapid Covid test contract

By Josh White

Date: Tuesday 17 May 2022

LONDON (ShareCast) - (Sharecast News) - Rapid test developer and manufacturer Abingdon Health announced a "significant contract" with a European customer on Friday, for the production of lateral flow device (LFD) components for a Covid-19 antigen test.
The AIM-traded firm said the contract was for an initial 12-month period, with an option to extend, and would start with the primary production of the key biochemical-sprayed nitrocellulose component of the LFD.

It said there was also an option to expand to other aspects of device manufacture, including production and lamination of other membrane components, and ultimately production of complete foiled devices.

The contract was with an unnamed European customer, with the initial phase worth a minimum of £2.7m based on minimum specified monthly order quantities and pricing at current sterling-dollar exchange rates, for the first year.

All raw materials required for production would be provided by the customer.

Abingdon said there would be an initial technical transfer process, paid for by the customer, which was expected to take about two months.

"We are pleased to have signed this contract with our European partner," said chief executive officer Chris Yates.

"The contract highlights the strengths of Abingdon's flexibility in being able to offer a range of first-class contract services across primary and secondary production.

"We continue to make commercial progress in other areas and look forward to updating the market in due course."

At 1314 BST, shares in Abingdon Health were up 25.85% at 12.27p.

Reporting by Josh White at Sharecast.com.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

ABDX Market Data

Currency UK Pounds
Share Price 5.00p
Change Today 0.000p
% Change 0.00 %
52 Week High 37.89
52 Week Low 4.50
Volume 334,131
Shares Issued 121.72m
Market Cap £6.09m

ABDX Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
24.01% above the market average24.01% above the market average24.01% above the market average24.01% above the market average24.01% above the market average
8.11% above the sector average8.11% above the sector average8.11% above the sector average8.11% above the sector average8.11% above the sector average
Price Trend
70.62% below the market average70.62% below the market average70.62% below the market average70.62% below the market average70.62% below the market average
64.1% below the sector average64.1% below the sector average64.1% below the sector average64.1% below the sector average64.1% below the sector average
Income Not Available
Growth
15.06% below the market average15.06% below the market average15.06% below the market average15.06% below the market average15.06% below the market average
27.78% below the sector average27.78% below the sector average27.78% below the sector average27.78% below the sector average27.78% below the sector average

ABDX Dividends

No dividends found

Trades for 28-Nov-2022

Time Volume / Share Price
16:35 10,000 @ 5.00p
16:35 1 @ 5.00p
16:35 9,999 @ 5.00p
16:22 50 @ 5.00p
16:03 15,000 @ 4.70p

ABDX Key Personnel

CEO Chris Henry Francis Yates
CFO Melanie Ross

Top of Page